Pharmaceutical India's Bharat Biotech has sought full market approval for its COVID-19 vaccine, Covaxin, from the country’s drug regulator. The indigenous Covaxin was approved on January 3, 2021, in emergency-use authorization (EUA) mode and has been administered to millions of people across India, including children, reports The Pharma Letter’s local correspondent. 14 January 2022